Medical/Pharmaceuticals
From diagnosis to treatment, ZEISS introduces innovations across ZEISS Retina Workflow at EURETINA 2026
ZEISS Medical Technology advances its ZEISS Retina Workflow
2026-09-24 21:00
3000
Earendil Labs Announces Research Collaboration with Genentech to Discover and Develop Therapeutic Bispecific Antibodies in Oncology
WILMINGTON, Del., Sept. 24, 2026 /PRNewswire/ -- Earendil Labs, an AI-powered biotechnology company advancing next-generation biologics, today announced a research collaboration with Genentech, a member of the Roche Group, to discover and develop multiple therapeutic bispecific antibody programs ...
2026-09-24 19:00
2492
Carestream Healthcare International Launches STARVIEW Digital Radiography System
SHANGHAI, Sept. 24, 2026 /PRNewswire/ -- Carestream Healthcare International announces the launch of theCARESTREAM STARVIEW Digital Radiography System, a focused, floor-mounted DR room designed for routine radiographic imaging. Healthcare facilities modernize radiography for different reasons, fr...
2026-09-24 14:07
2089
NCCN Models How to Tailor Cancer Care for Different Regions During 2026 World Cancer Congress
National Cancer Control Plans can and should include regionally appropriate guidelines according to abstracts presented by the National Comprehensive Cancer Network during global event hosted by the Union of International Cancer Control. PLYMOUTH MEETING, Pa. and HONG KONG, Sept. 24, 2026 /PRNew...
2026-09-24 08:03
2300
Daewoong Pharmaceutical Presents Baseline Characteristics of 104 Patients in Global Phase 2 Trial for IPF Drug Candidate 'Bersiporocin' at ERS 2026
* 104 IPF patients enrolled in US and South Korea as global Phase 2 trial progresses toward completion * Study includes both antifibrotic-treated and untreated patients; top-line data expected in H1 2027 * First-in-class PRS inhibitor being developed as a potential new therapeutic option...
2026-09-24 08:00
3214
CooperVision Powers the Next Era of Eye Care with New Global Vision Centre and Major Pipeline Advancements
The Vision Centre Brings Industry Leading Innovation to Accelerate Breakthroughs in Eye Care ROCHESTER, N.Y., Sept. 23, 2026 /PRNewswire/ -- CooperVision today unveiled the grand opening of The Vision Centre, the company's new global innovation hub in Southampton, England, and announced six majo...
2026-09-23 22:15
3950
Werfen Announces US FDA 510(k) Clearance and CE Mark for Aptiva® Antiphospholipid Syndrome IgA Reagent
FDA Clearance and CE Mark Complete Aptiva's Antiphospholipid Syndrome Portfolio, Expanding Global Access to Comprehensive APS Testing SAN DIEGO, Sept. 23, 2026 /PRNewswire/ -- Werfen today announced that its Aptiva Antiphospholipid Syndrome (APS) Immunoglobulin A (IgA) Reagent has received both ...
2026-09-23 20:00
1861
HKSH Medical Group and United Imaging Mark Launch of Hong Kong's First Long-Axial PET/CT
HONG KONG, Sept. 23, 2026 /PRNewswire/ -- HKSH Medical Group (HKSH) and United Imaging Healthcare (United Imaging) announced on September 23 the arrival of Hong Kong's first long-axial PET/CT, the uMI Panorama GS, at HKSH Cancer Centre, providing a new technology platform for molecular imaging cl...
2026-09-23 18:30
1664
Leedon Technology Expands Healthcare Technical Capabilities with Authorised IMT Analytics Service Centre in Singapore
The new service centre builds on more than two decades of healthcare industry experience, expanding local calibration and technical support for medical gas flow devices and analysers SINGAPORE, Sept. 23, 2026 /PRNewswire/ -- Leedon Technology Pte Ltd, a Singapore-based healthcare solutions provi...
2026-09-23 18:17
3664
Innovent to Present New Clinical Data of Next-gen IO and ADC Pipeline at the 2026 ESMO Annual Meeting
SAN FRANCISCO and SUZHOU, China, Sept. 23, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmun...
2026-09-23 16:48
2332
Caliway Announces Positive Phase 2 Results of CBL-514 in Dercum's Disease, Achieving Primary Endpoint with Statistically Significant and Sustained Pain Reduction
* Primary Endpoint Achieved in CBL-0202DD Phase 2 Trial—CBL-514 delivered statistically significant pain reduction across both FAS and PP populations compared with placebo. * Expansion Opportunity Beyond Dercum's Disease—Study findings support the potential development of CBL-514 for Lipedema...
2026-09-23 10:08
1791
Novo receives Singapore approval for Wegovy® as first treatment for MASH with liver fibrosis
ESSENCE trial data showed 63% of participants receiving semaglutide achieved steatohepatitis resolution without worsening of liver fibrosis, compared with 34% receiving placebo, at Week 72. * Singapore's Health Sciences Authority (HSA) has approved Wegovy® (once-weekly injectable semaglutide 2...
2026-09-23 10:05
3459
GROWNSY Makes NANN Conference Debut, Partners with NANN and Pediatrician Dr. Molly O'Shea on NANNcast Episode Tackling Infant Nasal Congestion
The company exhibited for the first time at NANN's 42nd Annual Conference in West Palm Beach and will sponsor a NANNcast episode exploring why newborns are so vulnerable to nasal congestion — and what neonatal nurses and parents can do about it. NEW YORK, Sept. 22, 2026 /PRNewswire/ -- GROWNSY <...
2026-09-23 09:36
1156
Mayo Clinic Laboratories Invests in Pathology Asia Holdings and LifeStrands Genomics to Advance Diagnostics and Precision Medicine
SINGAPORE, Sept. 23, 2026 /PRNewswire/ -- Mayo Clinic Laboratories
2026-09-23 09:30
1380
XtalPi AI Enables Seven-Month PCC Nomination for Viva-Thera's MPER-Targeting HIV-1 Program
* Viva-Thera makes its public debut with four modalities pursuing HIV prevention, treatment and cure, supported by XtalPi's platform capabilities. * Viva-Thera combines its first atomic-resolution MPER-TMD-CT structure with XtalPi's AI and automation platform to advance a small-molecule PCC. ...
2026-09-23 01:36
1500
Tsingke Enables High-Throughput Validation of AI-Designed Proteins and Antibodies
BEIJING, Sept. 22, 2026 /PRNewswire/ -- Tsingke today announced an integrated high-throughput validation workflow designed to help researchers experimentally evaluate large libraries of AI-designed proteins and antibodies. Combining gene synthesis, parallel expression, high-throughput screening, ...
2026-09-22 22:22
1127
Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration
* New flagship facility provides hands-on access to Bio-Techne technologies, workflows and scientific expertise * Regional hub will support researchers and organizations across the DACH and broader EMEA regions * Center strengthens collaboration, training and innovation within Europe's life...
2026-09-22 21:00
2761
AIMD Expands A-LRYNGO, the World's First AI-Guided Video Laryngoscope, to Global Markets
Dual Korean Government Recognition Advances AI-Guided Intubation Toward a New Standard in Airway Management SEOUL, South Korea, Sept. 22, 2026 /PRNewswire/ -- AIMD Inc., a Korean medical technology company specializing in AI-powered emergency care, announced the global expansion ofA-LRYNGO™, the...
2026-09-22 21:00
1563
From Next-Gen AI to Surgical Robots: IEEE Celebrates the Technical Innovators Shaping the Future
World's leading technology and engineering community unveils 2027 Technical Field Awards, recognizing achievements in medical robotics, wireless networks, digital privacy, power electronics, computing technology, and more PISCATAWAY, N.J., Sept. 22, 2026 /PRNewswire/ -- Celebrating innovations r...
2026-09-22 21:00
1317
Kazia Therapeutics Announces Sovargen Co. Doses First Patient in Phase 1b/2a Trial of Paxalisib for Rare Seizure Disorders
Clinical Milestone Expands Development of Paxalisib Beyond Oncology and
Triggers $2 Million Payment to Kazia
SYDNEY, Sept. 22, 2026 /PRNewswire/ -- Kazia Therapeutics Limited
2026-09-22 19:30
2545
Week's Top Stories
Most Reposted
Cyient, 3-GIS Partner to Help Telecom and Utility Operators Turn Network Data into Operational Control
[Picked up by 1154 media titles]
2026-11-11 22:00Royal Bank of Canada announces agreement to acquire Yarra Capital Management
[Picked up by 1143 media titles]
2026-11-09 21:00Algolia Powers Orange with AI Agents for Billing Support: NYSE Content Update
[Picked up by 1121 media titles]
2026-11-06 22:06
Cision Report Reveals the Consumer Trends Hidden Between Search, Social, and AI
[Picked up by 1109 media titles]
2026-11-09 23:00
Poppi Founders Launch Hydration Brand jetty: NYSE Content Update
[Picked up by 1083 media titles]
2026-11-10 22:17
Most Read
DomoAI Launches InkoAI Agent - One Sentence to Ready-to-Post Video
2026-11-13 13:00
115492
Home Companion Robot Mobo to Debut Globally and Open Pre-orders as AiMOGA Showcases Its Robot Family at the 2026 OMODA & JAECOO International User Summit
2026-11-07 13:49
28168
SILVERSEA MARKS HISTORIC OPENING OF THE CORMORANT AT 55 SOUTH, THE SOUTHERNMOST HOTEL ON EARTH, OFFERING A NEW GATEWAY TO ANTARCTICA
2026-11-07 01:05
16425
